Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies
Autor: | Matthew E. Layton, Gary M. Pollack, John R. White, Brandon T. Gufford, Mary F. Paine, Garrett R. Ainslie, Jeannie M. Padowski |
---|---|
Rok vydání: | 2017 |
Předmět: |
Miosis
food.ingredient (+)-Naloxone 030226 pharmacology & pharmacy Mean Absorption Time General Biochemistry Genetics and Molecular Biology Grapefruit juice 03 medical and health sciences 0302 clinical medicine food Pharmacokinetics medicine 030212 general & internal medicine General Pharmacology Toxicology and Pharmaceutics Alfentanil business.industry General Neuroscience Opioid overdose General Medicine medicine.disease Confidence interval 3. Good health Anesthesia medicine.symptom business medicine.drug |
Zdroj: | Clinical and Translational Science. 10:380-386 |
ISSN: | 1752-8054 |
DOI: | 10.1111/cts.12473 |
Popis: | Easy-to-use naloxone formulations are needed to help address the opioid overdose epidemic. The pharmacokinetics of i.v., i.m., and a new i.n. naloxone formulation (2 mg) were compared in six healthy volunteers. Relative to i.m. naloxone, geometric mean (90% confidence interval [CI]) absolute bioavailability of i.n. naloxone was modestly lower (55%; 90% CI, 43-70% vs. 41%; 90% CI, 27-62%), whereas average (±SE) mean absorption time was substantially shorter (74 ± 8.8 vs. 6.7 ± 4.9 min). The opioid-attenuating effects of i.n. naloxone were compared with i.m. naloxone (2 mg) after administration of oral alfentanil (4 mg) to a separate group of six healthy volunteers pretreated with 240 mL of water or grapefruit juice. The i.m. and i.n. naloxone attenuated miosis by similar extents after water (40 ± 15 vs. 41 ± 21 h*%) and grapefruit juice (49 ± 18 vs. 50 ± 22 h*%) pretreatment. Results merit further testing of this new naloxone formulation. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |